APA (7th ed.) Citation

JC, C., T, T., M, N., A, W., LK, H., AA, S., . . . CE, S. (2024). Aberrant long-chain fatty acid metabolism associated with evolving systemic sclerosis-associated pulmonary arterial hypertension. American journal of physiology. Lung cellular and molecular physiology, 327(1), L54. https://doi.org/10.1152/ajplung.00057.2024

Chicago Style (17th ed.) Citation

JC, Coursen, et al. "Aberrant Long-chain Fatty Acid Metabolism Associated with Evolving Systemic Sclerosis-associated Pulmonary Arterial Hypertension." American Journal of Physiology. Lung Cellular and Molecular Physiology 327, no. 1 (2024): L54. https://doi.org/10.1152/ajplung.00057.2024.

MLA (9th ed.) Citation

JC, Coursen, et al. "Aberrant Long-chain Fatty Acid Metabolism Associated with Evolving Systemic Sclerosis-associated Pulmonary Arterial Hypertension." American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 327, no. 1, 2024, p. L54, https://doi.org/10.1152/ajplung.00057.2024.